ArticleBMJ open2025

Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.

Yu Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.